Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate Infusion vs Injections for PVR Prevention in Retinal Detachment
NCT06289205Phase 2Recruiting
- Sponsor
- University of Health Sciences Lahore
- Start
- Mar 2024
- Primary completion
- Feb 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methotrexate in Proliferative Vitreoretinopathy (PVR), sponsored by University of Health Sciences Lahore. Started Mar 2024; status: recruiting.
02
Drugs
methotrexate
03
Conditions
Proliferative Vitreoretinopathy (PVR)
Beyond the preview
Go deeper on NCT06289205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06289205.